Supporting a role for BRCA1/2 in GBC, the Breast Cancer linkage consortium studied coincident cancers among 681 individuals with breast or ovarian cancer and 3047 carriers of BRCA1 or BRCA2 variants. This evidence concerns the gene BRCA2 and cancer.